Home › Funds › TRV GP V, LLC › RAPP

TRV GP V, LLC position in RAPP

RAPPORT THERAPEUTICS INC · Health Care

TRV GP V, LLC reported holding 6,280,525 shares of RAPP (RAPPORT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$261.7M, representing 52.53% of its reported portfolio and ranking #1 among its reported holdings. TRV GP V, LLC has disclosed RAPP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)6.28M sh
Reported value held$261.71M
Portfolio Weight52.53%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TRV GP V, LLC's RAPP position evolved

TRV GP V, LLC first disclosed a stake in RAPP in Q4 2024 at 7,135,233 shares (US$126.6M). The position peaked in Q2 2026 at 6,280,525 shares, worth US$261.7M. Across 7 filings, TRV GP V, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 6,280,525 shares valued at US$261.7M — a reduction of -854,708 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2024 7.14M $126.58M New
Q1 2025 7.14M $71.57M Hold
Q2 2025 7.14M $81.13M Hold
Q3 2025 7.14M $211.92M Hold
Q4 2025 7.14M $216.48M Hold
Q1 2026 7.14M $223.26M Hold
Q2 2026 6.28M $261.71M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RAPP and 13F data

RAPP (RAPPORT THERAPEUTICS INC) is a Health Care company. 66 other funds we track also report a position in RAPP — the largest reported positions include ARCH Venture Management, LLC (US$155.4M), Cormorant Asset Management, LP (US$110.7M), Sofinnova Investments, Inc. (US$79.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RAPP

All RAPP fund holders →

FAQ

How long has TRV GP V, LLC held RAPP?

TRV GP V, LLC has disclosed RAPP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is TRV GP V, LLC's current position in RAPP?

As of Q2 2026, TRV GP V, LLC holds 6.28M shares of RAPP (RAPPORT THERAPEUTICS INC), valued at $261.71M, representing 52.53% of its reported portfolio and ranking #1.

Has TRV GP V, LLC been buying or selling RAPP?

In the latest 13F filing (Q2 2026), TRV GP V, LLC reduced its position in RAPP. The position peaked in Q2 2026 at 6.28M shares.

Which other funds hold RAPP?

Other major institutional holders of RAPP include ARCH Venture Management, LLC, Cormorant Asset Management, LP, Sofinnova Investments, Inc., among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.